Prostate cancer protein identified

A PROSTATE cancer protein has been identified that could lead to new diagnostic tests and treatments.

The protein is made by the PRKCZ gene, which has previously been shown to play a role in aggressive prostate cancer. Scientists found one version of the gene produced a protein only made in prostate cancer cells.

They believe it could be used as a disease marker, and provide a new target for drug treatment. Professor Chris Foster, from the University of Liverpool, said: “We now need to discover what role this protein is playing in prostate cancer.”